Ali R. Roghanizad

Ali R. Roghanizad

Auto-generated profile, based on publicly available information

Ali R. Roghanizad

Department of Biomedical Engineering, Duke University, 534 Research Dr, # 448, Durham, NC, 27710, United States, 1 9542960640

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Sensors
Verified
Journal Article
Open access
PDF file
WWWill Ke Wang
Will Ke Wang
ICIna Chen
Ina Chen
LHLeeor Hershkovich
Leeor Hershkovich
JYJiamu Yang
Jiamu Yang
ASAyush Shetty
Ayush Shetty
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
Background: Digital clinical measures collected via various digital sensing technologies such as smartphones, smartwatches, wearables, and ingestible and implantable sensors are increasingly used by individuals and clinicians to capture the health outcomes or behavioral and physiological characteristics of individuals. Time series classification (TSC) is very commonly used for modeling digital clinical measures. While deep learning models for TSC are very common and powerful, there exist some fundamental challenges. This review presents the non-deep learning models that are commonly used for time series classification in biomedical applications that can achieve high performance. Objective: We performed a systematic review to characterize the techniques that are used in time series classification of digital clinical measures throughout all the stages of data processing and model building. Methods: We conducted a literature search on PubMed, as well as the Institute of Electrical and Electronics Engineers (IEEE), Web of Science, and SCOPUS databases using a range of search terms to retrieve peer-reviewed articles that report on the academic research about digital clinical measures from a five-year period between June 2016 and June 2021. We identified and categorized the research studies based on the types of classification algorithms and sensor input types. Results: We found 452 papers in total from four different databases: PubMed, IEEE, Web of Science Database, and SCOPUS. After removing duplicates and irrelevant papers, 135 articles remained for detailed review and data extraction. Among these, engineered features using time series methods that were subsequently fed into widely used machine learning classifiers were the most commonly used technique, and also most frequently achieved the best performance metrics (77 out of 135 articles). Statistical modeling (24 out of 135 articles) algorithms were the second most common and also the second-best classification technique. Conclusions: In this review paper, summaries of the time series classification models and interpretation methods for biomedical applications are summarized and categorized. While high time series classification performance has been achieved in digital clinical, physiological, or biomedical measures, no standard benchmark datasets, modeling methods, or reporting methodology exist. There is no single widely used method for time series model development or feature interpretation, however many different methods have proven successful.

3 November 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LLLauren Lederer
Lauren Lederer
ABAmanda Breton
Amanda Breton
HJHayoung Jeong
Hayoung Jeong
HMHiral Master
Hiral Master
ARAli R Roghanizad
Ali R Roghanizad
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
Wearable digital health technologies (DHTs) have become increasingly popular in recent years, enabling more capabilities to assess behaviors and physiology in free-living conditions. The All of Us Research Program (AoURP), a National Institutes of Health initiative that collects health-related information from participants in the United States, has expanded its data collection to include DHT data from Fitbit devices. This offers researchers an unprecedented opportunity to examine a large cohort of DHT data alongside biospecimens and electronic health records. However, there are existing challenges and sources of error that need to be considered before using Fitbit device data from the AoURP. In this viewpoint, we examine the reliability of and potential error sources associated with the Fitbit device data available through the AoURP Researcher Workbench and outline actionable strategies to mitigate data missingness and noise. We begin by discussing sources of noise, including (1) inherent measurement inaccuracies, (2) skin tone–related challenges, and (3) movement and motion artifacts, and proceed to discuss potential sources of data missingness in Fitbit device data. We then outline methods to mitigate such missingness and noise in the data. We end by considering how future enhancements to the AoURP’s Fitbit device data collection methods and the inclusion of new Fitbit data types would impact the usability of the data. Although the reliability considerations and suggested literature are tailored toward Fitbit device data in the AoURP, the considerations and recommendations are broadly applicable to data from wearable DHTs in free-living conditions.

4 January 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
HJHayoung Jeong
Hayoung Jeong
ARAli R. Roghanizad
Ali R. Roghanizad
HMHiral Master
Hiral Master
JKJuseong Kim
Juseong Kim
AKAymone Kouame
Aymone Kouame
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
Large-scale and detailed analyses of activity in the United States (US) remain limited. In this work, we leveraged the comprehensive wearable, demographic, and survey data from the All of Us Research Program, the largest and most diverse population health study in the US to date, to apply and extend the previous global findings on activity inequality within the context of the US. We found that daily steps differed by sex at birth, age, body characteristics, geography, and built environment. Quantifying activity inequality using the modified Gini index, we found a strong correlation with obesity prevalence (R2 = 0.804) and a moderate correlation with perceived walkability (R2 = 0.426) and the activity gender gap (R2 = 0.385). This study demonstrates the value of digital health technologies in exploring and understanding public health practices while highlighting the need to examine complexities, including biopsychosocial factors that may contribute to activity inequality.

29 August 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
WWWill Ke Wang
Will Ke Wang
ICIna Chen
Ina Chen
LHLeeor Hershkovich
Leeor Hershkovich
JYJiamu Yang
Jiamu Yang
ASAyush Shetty
Ayush Shetty
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
Background: Digital clinical measures collected via various digital sensing technologies such as smartphones, smartwatches, wearables, ingestible, and implantable are increasingly used by individuals and clinicians to capture health outcomes or behavioral and physiological characteristics of individuals. Time series classification (TSC) is very commonly used in modeling digital clinical measures. While deep learning models for TSC are very common and powerful, there exist some fundamental challenges. This review presents non-deep learning models commonly used for time series classification in biomedical applications that achieve high performance. Objective: We performed a systematic review to characterize the techniques used in time series classification of digital clinical measures throughout all stages of data processing and model building. Methods: We conducted a literature search on PubMed, and the Institute of Electrical and Electronics Engineers (IEEE), Web of Science, and SCOPUS databases using a range of search terms to retrieve peer-reviewed articles reporting academic research on digital clinical measures in the five year period between June 2016 and June 2021. We identified and categorized research studies based on the types of classification algorithms and sensor input types. Results: We found 452 papers in total from four different databases: PubMed, IEEE, Web of Science Database, and SCOPUS. After removing duplicates and irrelevant papers, 135 articles remained for detailed review and data extraction. Among these, engineered features using time series methods that were subsequently fed into widely-used machine learning classifiers was the most commonly used technique and also most frequently achieved the best performance metrics (77 out of 135 articles). Statistical modeling (24 out of 135 articles) algorithms were the second most common and also second best classification technique. Wavelet-based classification models (8 out of 135 articles) were also common. Electroencephalogram (29 out of 135 articles) was the most common data type used as an input. Accuracy was the most commonly reported performance metric, with 67.65% of articles reporting on accuracy. In this review paper, we provide summaries of signal pre-processing methods, feature engineering and selection methods, time series models, as well as model interpretations. Importantly, we found that about 50% of the papers only report one performance metric, which may result in a skewed view of overall performance. Conclusion: While high time series classification performance has been achieved in digital clinical, physiological, or biomedical measures, no standard benchmark datasets, modeling methods, or reporting methodology exist. There is no single widely used method for time series model development or feature interpretation– many different methods have proven successful.

5 November 2020 in Blood
Verified
Journal Article
Open access
ASAnna Shvygina
Anna Shvygina
ARAli R. Roghanizad
Ali R. Roghanizad
TDThomas Diller
Thomas Diller
EMEmily Moses
Emily Moses
VPVydia Permashwar
Vydia Permashwar
JVJennifer Vaughn
Jennifer Vaughn
Introduction: Peripheral perfusion limitation is a potential biomarker of the severity and progression of sickle cell disease (SCD). Currently, there exists no direct means of quantifying perfusion deficits in SCD patients. Transcranial doppler ultrasonography offers a surrogate measure of perfusion and is highly operator dependent. Routine clinical screening of perfusion abnormalities with alternative modalities (e.g., positron emission tomography and magnetic resonance imaging) is challenging given high cost, requirement for sedation in young children, and need for trained personnel. The Combined Heat-Flux Temperature Sensor (CHFT+) is a novel noninvasive bio-heat perfusion sensor that measures peripheral perfusion in real time at depths of up to 1 cm by applying a minimal amount of heat to the skin surface. Because perfusion limitation is a hallmark of SCD, an improved understanding of its pathophysiology could potentially empower both patients and their physicians. The aim of this study was to evaluate the ability of the CHFT+ to detect differences in peripheral perfusion between healthy volunteers and patients with SCD. Materials and Methods: The present study is an ongoing, non-randomized pilot study that aims to test the CHFT+ sensor's ability to detect impaired perfusion is pediatric SCD patients. We are actively enrolling pediatric patients (age 3-17) with SCD and healthy volunteers from 2 pediatric clinics to test the sensor. Peripheral perfusion measurements were obtained at 5 locations on the body (e.g., forehead, forearms, palms). All measurements were normalized against forehead perfusion values to account for individual variations. An independent-samples t-test was conducted to compare average rates of perfusion in patients with SCD and in healthy volunteers. The goal enrollment for this study is 52 patients (26 with SCD, 26 healthy controls) to detect a two-fold difference in perfusion with a power of 0.80. Interim Results and Discussion: To date, 31 participants have been enrolled, 10 (32%) of whom were patients with SCD. Overall, average perfusion rates were lower in the SCD group when compared to the healthy group, although these differences were not statistically significant. Representative measurements of perfusion in the right and left forearms, normalized against forehead rates, are shown in Figure 1. Normalized left forearm perfusion in healthy controls vs. SCD patients: avg = 1.77, SD = 0.95 vs. avg = 1.28, SD = 0.52, respectively [t(27) = 1.80, p = 0.08]; see Fig. 1a. Normalized right forearm perfusion in healthy controls vs. SCD patients: avg = 1.80, SD = 1.01 vs. avg = 1.31, SD = 0.60, respectively [t(25) = 1.55, p = 0.13]); see Fig. 1b. Conclusions:At this time, our data suggest that the novel CHFT+ sensor is capable of detecting a modest difference in peripheral perfusion in children with SCD versus healthy controls, but this difference is not statistically significant due to limited enrollment. Additional enrollment will further define the utility of the CHFT+ sensor in this clinical population. Future studies should evaluate the sensor's capability to detect perfusion deficits in the adult SCD population, as well as measure perfusion variations that occur during SCD vaso-occlusive crises. Disclosures Diller: FluxTeq:Other: Partner.

27 March 2026 in JMIR Formative Research
Verified
Journal Article
Open access
YJYihang Jiang
Yihang Jiang
CSConnor Spies
Connor Spies
ARAli R Roghanizad
Ali R Roghanizad
WWWill Ke Wang
Will Ke Wang
SBSatasuk Joy Bhosai
Satasuk Joy Bhosai
Jessilyn DunnJessilyn Dunn
Jessilyn Dunn
Background: Oxygen saturation is a crucial metric used for monitoring patients with lung disease or respiratory illness who are at risk of hypoxemia (low blood oxygen saturation). Early and accurate identification of abnormal oxygen saturation is important for these patients, who may develop significant desaturation and hypoxemia symptoms during their daily activities. Objective: This study aimed to evaluate the accuracy of Apple Watch Series 7 and a clinical-grade pulse oximeter, Masimo MightySat Rx, under hypoxemia and to assess whether measurement error is influenced by the oxygen desaturation rate (ODR). Methods: We calculated the ODR of each measurement and conducted a comparative analysis of the displayed oxygen saturation readings from both the Masimo MightySat Rx finger pulse oximeter and Apple Watch Series 7 with arterial blood oxygen saturation (SaO 2 ) readings obtained from a blood gas analyzer. Results: Both the Masimo MightySat Rx pulse oximeter and the Apple Watch Series 7 tended to overestimate oxygen saturation. The pulse oximeter readings were more likely to fall within 2% of the acceptable (as specified by Masimo) peripheral oxygen saturation (SpO ₂ ) error range than the Apple Watch (49.03% vs 32.14%). Notably, both devices had limitations under low oxygen saturation levels (<88%), with an accuracy root mean square difference (A rms ) of 3.52% (95% CI 3.18%‐3.86%) and 5.82% (95% CI 5.32%‐6.31%) for the Masimo MightySat Rx and Apple Watch Series 7, respectively. Among the blood oxygen measurements taken during a high ODR (ie, ≥2% SpO 2 per minute), which is a rate clinically correlated with sleep apnea, the A rms increased slightly by 0.75% for the Masimo MightySat Rx and decreased by 0.28% for the Apple Watch Series 7. Conclusions: Both devices consistently overestimated SpO 2 , with accuracy declining notably during hypoxemia. The Apple Watch Series 7 mean bias suggests a likelihood of missing instances of hypoxemia, particularly at arterial oxygen saturation values below but close to 88%. Both the Apple Watch Series 7 and Masimo MightySat Rx exhibited A rms values exceeding the US Food and Drug Administration threshold under conditions of hypoxemia. While past studies have implicated high ODRs in increasing measurement error, we found no statistically significant relationship between ODR and measurement error for either device. Overall, our findings of SpO 2 overestimation and high A rms values underscore the need for caution when interpreting oxygen saturation values from these devices. The small sample size and limited diversity in skin tone and age restrict the generalizability of our findings. Future studies should include larger and more diverse populations to evaluate the performance of wearable-based pulse oximetry.